These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17318473)

  • 21. Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer.
    Araújo JE; López-Fernández H; Diniz MS; Baltazar PM; Pinheiro LC; da Silva FC; Carrascal M; Videira P; Santos HM; Capelo JL
    Talanta; 2018 Apr; 180():36-46. PubMed ID: 29332824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revealing urologic diseases by proteomic techniques.
    Lee SW; Lee KI; Kim JY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):203-13. PubMed ID: 15652810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review.
    Sanguedolce F; Russo D; Mancini V; Selvaggio O; Calò B; Carrieri G; Cormio L
    Int J Surg Pathol; 2019 Apr; 27(2):120-133. PubMed ID: 30509113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
    Röwer C; Koy C; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
    J Am Soc Mass Spectrom; 2011 Mar; 22(3):440-56. PubMed ID: 21472563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
    Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
    Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Label-Free Proteomics for Quantitative Analysis of Urothelial Carcinoma and Cystitis Tissue.
    Witzke KE; Großerueschkamp F; Gerwert K; Sitek B
    Methods Mol Biol; 2021; 2228():283-292. PubMed ID: 33950498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
    Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
    Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
    Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
    Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of urinary proteomics in early diagnosis of bladder urothelial carcinoma].
    Li HJ; Li CY; Zhang T; Chen JJ; Wang SX; Chang JW; Jiang SF; Zhang GL; Li JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Apr; 31(4):262-5. PubMed ID: 23595302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers.
    Quanico J; Franck J; Gimeno JP; Sabbagh R; Salzet M; Day R; Fournier I
    Chem Commun (Camb); 2015 Mar; 51(22):4564-7. PubMed ID: 25490716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin.
    Varinot J; Cussenot O; Roupret M; Conort P; Bitker MO; Chartier-Kastler E; Cheng L; Compérat E
    Virchows Arch; 2013 Dec; 463(6):803-9. PubMed ID: 24146108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DiaPat test for prostate cancer diagnosis].
    Semjonow A
    Urologe A; 2007 Oct; 46(10):1428. PubMed ID: 17846740
    [No Abstract]   [Full Text] [Related]  

  • 35. Classification of proteomic data with multiclass Logistic Partial Least Squares algorithm.
    Liu Z; Chen D; Tian JP
    Int J Bioinform Res Appl; 2008; 4(1):1-10. PubMed ID: 18283025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
    Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
    Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
    Moreira JM; Ohlsson G; Gromov P; Simon R; Sauter G; Celis JE; Gromova I
    Mol Cell Proteomics; 2010 Jan; 9(1):161-77. PubMed ID: 19783793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
    Kistler AD; Serra AL; Siwy J; Poster D; Krauer F; Torres VE; Mrug M; Grantham JJ; Bae KT; Bost JE; Mullen W; Wüthrich RP; Mischak H; Chapman AB
    PLoS One; 2013; 8(1):e53016. PubMed ID: 23326375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.
    Barresi V; Ieni A; Cardia R; Licata L; Vitarelli E; Reggiani Bonetti L; Tuccari G
    APMIS; 2016 Mar; 124(3):188-93. PubMed ID: 26590121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proteome-based diagnostic and prognostic biomarkers of prostate cancer].
    Neuhaus J; Schiffer E; Siwy J; Mannello F; Horn LC; Stolzenburg JU
    Urologe A; 2013 Sep; 52(9):1251-5. PubMed ID: 24026060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.